HEC110114 tablet

DRUG2 trials

Sponsors

Sunshine Lake Pharma Co., Ltd.

Conditions

Chronic Hepatitis C

Phase 1

The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects

CompletedNCT03903081

Sunshine Lake Pharma Co., Ltd.Chronic Hepatitis C

Start: 2019-03-06End: 2019-10-29Updated: 2020-03-18

The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects

CompletedNCT04202952

Sunshine Lake Pharma Co., Ltd.Chronic Hepatitis C

Start: 2020-07-06End: 2020-08-27Updated: 2020-09-10